TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
40 hedge funds and large institutions have $10.9M invested in Titan Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $14.1M → $10.9M (-$3.25M)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
Holders
40
Holding in Top 10
–
Calls
$736K
Puts
$3K
Top Buyers
| 1 | +$2.65M | |
| 2 | +$296K | |
| 3 | +$59.3K | |
| 4 |
SG Americas Securities
New York
|
+$50K |
| 5 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
+$39K |
Top Sellers
| 1 | -$332K | |
| 2 | -$260K | |
| 3 | -$203K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$186K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$95K |